Dipotassium glycyrrhizinate

CAS No. 68797-35-3

Dipotassium glycyrrhizinate ( —— )

Catalog No. M20484 CAS No. 68797-35-3

Dipotassium glycyrrhizinate is an anionic surfactant having anti-allergic and anti-inflammatory activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dipotassium glycyrrhizinate
  • Note
    Research use only not for human use.
  • Brief Description
    Dipotassium glycyrrhizinate is an anionic surfactant having anti-allergic and anti-inflammatory activities.
  • Description
    Dipotassium glycyrrhizinate is an anionic surfactant having anti-allergic and anti-inflammatory activities.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others
  • Indication
    ——

Chemical Information

  • CAS Number
    68797-35-3
  • Formula Weight
    899.12
  • Molecular Formula
    C42H60K2O16
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL (27.8 mM)
  • SMILES
    [K+].[K+].[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C([O-])=O)C([O-])=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lee S H Bae I H Choi H et al. Ameliorating effect of dipotassium glycyrrhizinate on an IL-4- and IL-13-induced atopic dermatitis-like skin-equivalent model[J]. Archives of Dermatological Research 2018.
molnova catalog
related products
  • DS-1040 tosylate

    DS-1040 tosylate (DS1040)is a small molecule inhibitor of the activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50 of 1.7 ng/mL for rabbit TAFIa.

  • AM966

    AM966, a excellent affinity, specific, oral LPA1(IC50=17 nM) antagonist, suppresses LPA-stimulated intracellular calcium release.

  • Neomangiferin

    Neomangiferin has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats.